What Turns Benign Central Nervous System Tumors Deadly
More than one in three tumors that affect the central nervous system are meningiomas and most are benign. However, some can turn deadly. In a new study, Yale researchers identified genetic abnormalities that mark atypical meningiomas, which have a 40 percent chance of recurring after surgical removal and are marked by a shorter survival rate than benign tumors. The new genetic analysis has identified molecular mechanisms involved in the formation of primary atypical meningiomas. “The tumor cells behave more like stem cells. They are less specialized and divide rapidly,” said Yale’s Akdes Serin Harmanci, the first author of the paper.
Click here to read more.
International Conference on Dual Diagnosis and Disorders
Nov. 14-15, 2018; Melbourne, Austrailia
Microsurgical Approaches to Aneurysms and Skull Base Diseases 2018
Nov. 15-17, 2018; Jacksonville, Fla.
2018 Mayo Clinic Multidisciplinary Spine Care Conference
Nov. 16-17, 2018; Amelia Island, Fla.
Craniofacial Surgery and Transfacial Approaches to the Skull Base
Nov. 30-Dec. 2, 2018; St. Louis
Comprehensive Endoscopic Endonasal Surgery of the Skull Base Course
Dec. 5-8, 2018; Pittsburgh